AETHLON MEDICAL INC
Data quality: 83%
AEMD
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
$2.22
▼
$0.01
(-0.45%)
Mkt Cap: 3.48 M
Price
$2.22
Mkt Cap
3.48 M
Day Range
$2.19 — $2.22
52-Week Range
$1.36 — $35.20
Volume
4,155
Open $2.19
50D / 200D Avg
$2.15
3.36% above
50D / 200D Avg
$6.52
65.93% below
Quick Summary
Key Takeaways
Negative free cash flow of -6.92 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-184.96%
Below sector avg (-51.02%)
ROIC-91.54%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio5.68
Interest Coverage-68.71
Valuation
PE (TTM)
-0.30
Above sector avg (-1.98)
P/B Ratio0.52
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.3 | -2.0 |
| P/B | 0.5 | 5.1 |
| ROE % | -185.0 | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -11.52 M |
| ROE | -184.96% | ROA | -149.83% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -6.92 M |
| ROIC | -91.54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 5.68 |
| Interest Coverage | -68.71 | Asset Turnover | N/A |
| Working Capital | 5.88 M | Tangible Book Value | 6.71 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.30 | Forward P/E | N/A |
| P/B Ratio | 0.52 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -198.61% | ||
| Market Cap | 3.48 M | Enterprise Value | -3.47 M |
| Per Share | |||
| EPS (Diluted TTM) | -18.98 | Revenue / Share | N/A |
| FCF / Share | -4.41 | OCF / Share | -4.41 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 60.05% |
| SBC-Adj. FCF | -7.28 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 0.0 | 574,245.0 | 294,165.0 | 659,104.0 |
| Net Income | -13.39 M | -12.21 M | -12.03 M | -10.42 M | -7.89 M |
| EPS (Diluted) | -8.58 | -4.86 | -0.59 | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -9.34 M | -12.64 M | -11.90 M | -10.42 M | -7.89 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 2.21 M | 2.52 M | 2.75 M | 2.34 M | 2.07 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 339,559.0 | 359,057.0 | 240,892.0 | 123,685.0 | 39,939.0 |
| Interest Expense | 10,109.0 | — | — | — | 1,580.0 |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 7.36 M | 8.25 M | 17.51 M | 19.42 M | 10.67 M |
| Total Liabilities | 2.24 M | 2.48 M | 2.44 M | 2.43 M | 1.38 M |
| Shareholders' Equity | 5.12 M | 5.77 M | 15.06 M | 17.13 M | 9.43 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 5.50 M | 5.44 M | 14.53 M | — | 9.86 M |
| Current Assets | 5.95 M | 6.23 M | 15.09 M | 18.16 M | 10.35 M |
| Current Liabilities | 1.90 M | 1.83 M | 1.51 M | 1.82 M | 1.38 M |
{"event":"ticker_viewed","properties":{"ticker":"AEMD","listing_kind":"stock","pathname":"/stocks/aemd","exchange":"Nasdaq","country":"US"}}